Encore Consumer Capital announces sale of Isopure to Glanbia
Robert Brown, managing director of Encore Consumer Capital, said, "Isopure’s founder Hal Katz decided to bring on a strategic and financial partner in 2007, and Encore was well
Robert Brown, managing director of Encore Consumer Capital, said, "Isopure’s founder Hal Katz decided to bring on a strategic and financial partner in 2007, and Encore was well
Modeled after breath freshening strips already well-known to most consumers, the MacuStrip will deliver exact doses of medical-grade vitamins in the simplest manner possible. The MacuStrip is slated
"Our goal is to help MissionPoint members improve their health status," said Jason Dinger, CEO of MissionPoint Health Partners. "In our experience with managing the health of populations,
Vaxart’s founder and chief scientific officer, Sean Tucker, PhD, discussed the data in a presentation today at the 15th Annual World Vaccine Congress in Brussels. "A tablet vaccine
"We are very excited having selected PPD, one of the world’s leading contract research organizations, to be our strategic clinical development partner in advancing our assets through the
The audit will be conducted in two phases, both of which are expected to be completed by early November 2014. In the first phase, INC Research Quality and
Orexo anticipates a potential approval of the expanded label during the third quarter 2015. The application for initiation of treatment is supported by the data from the ISTART
Hodgkin lymphoma is a cancer of the immune system that is marked by the presence of a type of cell called the Reed-Sternberg cell. The two major types
"We are elated following the FDA’s approval of our IND application for MT-3724 and are eager to begin the next steps of our clinical journey with Veristat. Veristat
The Company will be presenting these findings today during a poster session at the American Neurological Association’s Annual Meeting in Baltimore, Maryland. Concert expects to initiate a Phase